GERON CORP Institutional holders
Original reported balances and amendments, ordered by publication. Calculated values use only evidence known at that publication; unavailable values remain missing.
| Filed | Holder | Type | Reported balance date | Reported shares | Value at publication | Price date used |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
|---|
| Wave Life Sciences, Inc. (WVE) | | $0.780B | -5.56 |
|---|
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
|---|
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
|---|